Xiao-hui He

Gemcitabine-based combination regimen in patients with peripheral T-cell lymphoma

P. Liu, Yuankai Shi, Jian-liang Yang, 2013, Medical Oncology.

GDP (Gemcitabine, Dexamethasone, and Cisplatin) Is Highly Effective and Well-Tolerated for Newly Diagnosed Stage IV and Relapsed/Refractory Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type

P. Liu, Yuankai Shi, Ye-Xiong Li, 2016, Medicine.

Chinese a Nti鄄 Cancer a Ssociation

P. Liu, Yuankai Shi, L. Xue, 2022 .

Phase 2 Study of First-line Intensity Modulated Radiation Therapy Followed by Gemcitabine, Dexamethasone, and Cisplatin for High-Risk, Early Stage Extranodal Nasal-Type NK/T-Cell Lymphoma: The GREEN Study.

P. Liu, Shulian Wang, Ye-Xiong Li, 2018, International journal of radiation oncology, biology, physics.

High-dose therapy and autologous stem cell transplantation in peripheral T-cell lymphoma: treatment outcome and prognostic factor analysis

P. Liu, Yuankai Shi, Sheng Yang, 2013, International Journal of Hematology.

Amino-metalloporphyrin polymers derived Fe single atom catalysts for highly efficient oxygen reduction reaction

Hongbing Ji, Xiaohui He, Y. Meng, 2020, Science China Chemistry.

Survival and pretreatment prognostic factors for extensive‐stage small cell lung cancer: A comprehensive analysis of 358 patients

Junling Li, Yuankai Shi, Yan Wang, 2021, Thoracic cancer.